We are live on
!
Find out more
Jim Simons Renaissance Technologies
AUM
$72.6B
1-Year Est. Return
54.88%
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
This Fund
S&P 500
This Quarter
Est. Return
+6.82%
1 Year Est. Return
+54.88%
3 Year Est. Return
+169.34%
5 Year Est. Return
+186.18%
10 Year Est. Return
+887.93%
AUM
$97.3B
AUM Growth
+$5.53B
(+6%)
Cap. Flow
+$1.37B
Cap. Flow
% of AUM
1.41%
Top 10 Holdings %
Top 10 Hldgs %
9.68%
Holding
3,734
New
508
Increased
1,623
Reduced
1,169
Closed
410
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$327M |
| 2 |
Chipotle Mexican Grill
CMG
|
+$271M |
| 3 |
Chevron
CVX
|
+$264M |
| 4 |
JPMorgan Chase
JPM
|
+$233M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$707M |
| 2 |
Johnson & Johnson
JNJ
|
+$396M |
| 3 |
Amazon
AMZN
|
+$312M |
| 4 |
Walmart Inc
WMT
|
+$285M |
| 5 |
Intuitive Surgical
ISRG
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.72% |
| 2 | Technology | 15.53% |
| 3 | Financials | 11.25% |
| 4 | Consumer Discretionary | 9.26% |
| 5 | Real Estate | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Kimbell Royalty Partners
KRP
$1.54B
| $1.7M | ﹤0.01% |
86,755
+36,040
| +71% | +$792K |
|
2352
Turkcell
TKC
$4.68B
| $1.7M | ﹤0.01% |
353,019
-686,200
| -66% | -$3.63M |
|
2353
CarParts.com
PRTS
$48.4M
| $1.7M | ﹤0.01% |
109,610
+1,720
| +2% | +$25.1K |
|
|
GES
2354
DELISTED
Guess Inc
GES
| $1.7M | ﹤0.01% |
75,000
-142,954
| -66% | -$3.24M |
|
2355
Masco
MAS
$14.7B
| $1.7M | ﹤0.01% |
+46,300
| New | +$1.78M |
|
|
TIVO
2356
DELISTED
Tivo Inc
TIVO
| $1.7M | ﹤0.01% |
136,135
+38,900
| +40% | +$503K |
|
|
NVTR
2357
DELISTED
Nuvectra Corporation Common Stock
NVTR
| $1.7M | ﹤0.01% |
77,100
+49,700
| +181% | +$956K |
|
|
CIVI
2358
DELISTED
Civitas Solutions, Inc.
CIVI
| $1.7M | ﹤0.01% |
114,935
-5,465
| -5% | -$86.2K |
|
|
ALDR
2359
DELISTED
Alder Biopharmaceuticals
ALDR
| $1.69M | ﹤0.01% |
101,500
-333,300
| -77% | -$6.02M |
|
2360
Hallador Energy
HNRG
$757M
| $1.69M | ﹤0.01% |
271,256
+54,456
| +25% | +$344K |
|
|
BMCH
2361
DELISTED
BMC Stock Holdings, Inc
BMCH
| $1.69M | ﹤0.01% |
+90,400
| New | +$1.96M |
|
|
ICAD
2362
DELISTED
iCAD Inc
ICAD
| $1.68M | ﹤0.01% |
577,960
+68,200
| +13% | +$202K |
|
2363
ASE Group
ASX
$102B
| $1.68M | ﹤0.01% |
347,806
-246,454
| -41% | -$1.17M |
|
|
OXFD
2364
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $1.68M | ﹤0.01% |
103,300
+82,242
| +391% | +$1.18M |
|
|
ASCMA
2365
DELISTED
Ascent Capital Group, Inc. Series A
ASCMA
| $1.68M | ﹤0.01% |
947,100
+10,900
| +1% | +$28K |
|
|
ACET
2366
DELISTED
Aceto Corp
ACET
| $1.67M | ﹤0.01% |
739,000
+233,400
| +46% | +$746K |
|
|
NITE
2367
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
| $1.67M | ﹤0.01% |
+81,700
| New | +$1.68M |
|
2368
BioCryst Pharmaceuticals
BCRX
$2.43B
| $1.66M | ﹤0.01% |
217,203
-177,378
| -45% | -$1.19M |
|
2369
Lisata Therapeutics
LSTA
$9.91M
| $1.66M | ﹤0.01% |
18,724
+5,620
| +43% | +$461K |
|
|
TCON
2370
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
| $1.66M | ﹤0.01% |
4,041
+441
| +12% | +$204K |
|
2371
iShares Select Dividend ETF
DVY
$24.1B
| $1.66M | ﹤0.01% |
16,600
+11,000
| +196% | +$1.1M |
|
2372
Investar Holding Corp
ISTR
$426M
| $1.66M | ﹤0.01% |
61,648
+4,248
| +7% | +$116K |
|
|
AXAS
2373
DELISTED
Abraxas Petroleum Corp
AXAS
| $1.66M | ﹤0.01% |
35,515
+4,450
| +14% | +$218K |
|
|
MR
2374
DELISTED
Montage Resources Corporation Common Stock
MR
| $1.65M | ﹤0.01% |
92,605
-97,362
| -51% | -$2.23M |
|
2375
Talphera
TLPH
$64.4M
| $1.65M | ﹤0.01% |
21,435
-3,395
| -14% | -$218K |
|
Similar funds
BC
Jim Simons's Q3 2018 Portfolio in Review
As of Q3 2018, Jim Simons held 3,734 positions worth $97.3B, up 6% from $91.7B the previous quarter. Its ten largest holdings account for 9.7% of the portfolio.
Jim Simons's Q3 2018 filing shows 508 new, 1,623 increased, 1,169 reduced and 410 closed positions. Its largest new stake was JPMorgan Chase: 2,054,913 shares worth $232M. The largest sale was Apple, an estimated $707M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
- Jim Simons's largest Q3 2018 buy was JPMorgan Chase: 2,054,913 shares worth $232M.
- Jim Simons added most to Twenty-First Century Fox, Inc. Class A in Q3 2018, an estimated $327M increase.
- Jim Simons's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $396M.
- Jim Simons fully exited Apple in Q3 2018, selling an estimated $707M.
- Jim Simons's ten largest holdings make up 9.7% of its $97.3B portfolio in Q3 2018.
- Jim Simons opened 508 new positions and closed 410 in Q3 2018.
- Jim Simons's portfolio value rose 6% quarter-over-quarter to $97.3B.
Based on Renaissance Technologies's 13F filing for Q3 2018, filed 13 Nov 2018.